Experimental study of Xuefu Zhuyu Decoction induced participation of endothelial progenitor cells in the angiogenesis of the ischemic region.
- Author:
Dong GAO
1
;
Yu-Huan JIAO
;
Yi-Man WU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Cells, Cultured; Drugs, Chinese Herbal; pharmacology; Endothelial Cells; cytology; drug effects; Female; Ischemia; pathology; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Stem Cells; cytology; drug effects
- From: Chinese Journal of Integrated Traditional and Western Medicine 2012;32(2):224-228
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effects of Xuefu Zhuyu Decoction (XFZYD) on the angiogenesis and injury repair in the ischemic region.
METHODSThe ischemic hind limb rat model was established using Bletilla embolization. Endothelial progenitor cells (EPCs) were labeled with DAPI and injected into the model rats from the vena caudalis. Then rats were treated with different doses of XFZYD by gastrogavage. Blood was withdrawn. The granulation tissue and the muscle tissues from ischemic and necrotic portion were taken on the 3rd and 7th day of the medication. The samples were frozen and sliced to analyze the fluorescent expressions. The necrosis of each sample was observed by routine pathological section. The vessels number was counted. The serum NO levels were detected using nitrate reductase method. The macro-morphological observation of ischemic lower limbs were lasted for 30 days.
RESULTSAfter 3 and 7 days of medication, the fluorescence intensity of ischemic area and the number of granulation vessels were significantly more in the high dose XFZYD group than in the routine treatment group and the normal saline treatment groups. The aforesaid indices were significantly higher in the routine treatment group than in the normal saline treatment group after 7 days of medication. The serum NO concentrations were significantly lower in the normal saline group at other time points. On the 30th day of medication, the muscular atrophy of the ischemic hind limbs was the least significant in the high dose XFZYD group.
CONCLUSIONXFZYD could improve the ischemic necrosis by improving the NO level, inducing the EPCs' migration to the ischemic region, and promoting the angiogenesis.